COVID-19

A new study by Mayo Clinic investigators highlights the development and implementation of the healthcare organization’s large-scale COVID-19

People who tested positive for SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19),  after one or two vaccine doses had

After years of steady reductions in healthcare-associated infections, significantly higher rates of four out of six routinely tracked infections were

Novel coronavirus (COVID-19) vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their

People infected with the SARS-CoV-2 delta variant have approximately double the risk of hospitalization compared with those infected with the alpha

The U.S. Centers for Disease Control and Prevention (CDC) may have increased the threat of novel coronavirus (COVID-19) infection in the Black

Children who develop symptoms of the novel coronavirus (COVID-19) typically get better after six days, and the number who experience symptoms beyond

The U.S. Food and Drug Administration (FDA) has approved the first novel coronavirus (COVID-19) vaccination, the Pfizer-BioNTech COVID-19 Vaccine,